| D007223 |
Infant |
A child between 1 and 23 months of age. |
Infants |
|
| D009450 |
Neurodermatitis |
An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus. |
Lichen Simplex Chronicus,Neurodermatitis, Circumscribed,Neurodermatitis, Localized,Circumscribed Neurodermatitides,Circumscribed Neurodermatitis,Localized Neurodermatitides,Localized Neurodermatitis,Neurodermatitides,Neurodermatitides, Circumscribed,Neurodermatitides, Localized |
|
| D009824 |
Ointments |
Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. |
Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin |
|
| D011244 |
Pregnadienediols |
Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains. |
Dihydroxypregnadienes |
|
| D002648 |
Child |
A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. |
Children |
|
| D002675 |
Child, Preschool |
A child between the ages of 2 and 5. |
Children, Preschool,Preschool Child,Preschool Children |
|
| D002986 |
Clinical Trials as Topic |
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. |
Clinical Trial as Topic |
|
| D003872 |
Dermatitis |
Any inflammation of the skin. |
Dermatitides |
|
| D004341 |
Drug Evaluation |
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. |
Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation |
|
| D004485 |
Eczema |
A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents. |
Dermatitis, Eczematous,Eczematous Dermatitis |
|